Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Erdan Kayupov is active.

Publication


Featured researches published by Erdan Kayupov.


Journal of Arthroplasty | 2016

Hypoalbuminemia Independently Predicts Surgical Site Infection, Pneumonia, Length of Stay, and Readmission After Total Joint Arthroplasty

Daniel D. Bohl; Mary R. Shen; Erdan Kayupov; Craig J. Della Valle

This study investigates the association between preoperative hypoalbuminemia, a marker for malnutrition, and complications during the 30 days after total joint arthroplasty. Patients who underwent elective primary total hip and knee arthroplasty as part of the American College of Surgeons National Surgical Quality Improvement Program were identified. Outcomes were compared between patients with and without hypoalbuminemia (serum albumin concentration <3.5 g/dL) with adjustment for patient and procedural factors. A total of 49603 patients were included. In comparison to patients with normal albumin concentration, patients with hypoalbuminemia had a higher risk for surgical site infection, pneumonia, extended length of stay, and readmission. Future efforts should investigate methods of correcting nutritional deficiencies prior to total joint arthroplasty. If successful, such efforts could lead to improvements in short-term outcomes for patients.


Clinical Orthopaedics and Related Research | 2017

The Mark Coventry, MD, Award: Oral Antibiotics Reduce Reinfection After Two-Stage Exchange: A Multicenter, Randomized Controlled Trial

Jonathan M. Frank; Erdan Kayupov; Mario Moric; John Segreti; Erik N. Hansen; Curtis W. Hartman; Kamil T. Okroj; Katherine A. Belden; Brian Roslund; Randi Silibovsky; Javad Parvizi; Craig J. Della Valle

BackgroundMany patients develop recurrent periprosthetic joint infection after two-stage exchange arthroplasty of the hip or knee. One potential but insufficiently tested strategy to decrease the risk of persistent or recurrent infection is to administer additional antibiotics after the second-stage reimplantation.Questions/purposes(1) Does a 3-month course of oral antibiotics decrease the risk of failure secondary to infection after a two-stage exchange? (2) Are there any complications related to the administration of oral antibiotics after a two-stage exchange? (3) In those patients who develop a reinfection, is the infecting organism different from the initial infection?MethodsPatients at seven centers randomized to receive 3 months of oral antibiotics or no further antibiotic treatment after operative cultures after the second-stage reimplantation were negative. Adult patients undergoing two-stage hip or knee revision arthroplasty for a periprosthetic infection who met Musculoskeletal Infection Society (MSIS) criteria for infection at the first stage were included. Oral antibiotic therapy was tailored to the original infecting organism(s) in consultation with an infectious disease specialist. MSIS criteria as used by the treating surgeon defined failure. Surveillance of patients for complications, including reinfection, occurred at 3 weeks, 6 weeks, 3 months, 12 months, and 24 months. If an organism demonstrated the same antibiotic sensitivities as the original organism, it was considered the same organism; no DNA subtyping was performed. Analysis was performed as intent to treat with all randomized patients included in the groups to which they were randomized. A log-rank survival curve was used to analyze the primary outcome of reinfection. At planned interim analysis (enrollment is ongoing), 59 patients were successfully randomized to the antibiotic group and 48 patients to the control group. Fifty-seven patients had an infection after TKA and 50 after a THA. There was no minimum followup for inclusion in this analysis. The mean followup was 14 months in the antibiotic group and 10 months in the control group.ResultsPatients treated with oral antibiotics failed secondary to infection less frequently than those not treated with antibiotics (5% [three of 59] versus 19% [nine of 48]; hazard ratio, 4.37; 95% confidence interval, 1.297–19.748; p = 0.016). Three patients had an adverse reaction to the oral antibiotics severe enough to cause them to stop taking the antibiotics early, and four patients who were randomized to that group did not take the antibiotics as directed. With the numbers available, there were no differences between the study groups in terms of the likelihood that an infection after treatment would be with a new organism (eight of nine in the control group versus one of three in the treatment group, p = 0.087).ConclusionsThis multicenter randomized trial suggests that at short-term followup, the addition of 3 months of oral antibiotics appeared to improve infection-free survival. As a planned interim analysis, however, these results may change as the study reaches closure and the safety profile may yet prove risky. Further followup of this cohort of patients will be necessary to determine whether these preliminary results are durable over time.Level of EvidenceLevel I, therapeutic study.


Journal of Arthroplasty | 2018

The Alpha-Defensin Test for Diagnosing Periprosthetic Joint Infection in the Setting of an Adverse Local Tissue Reaction Secondary to a Failed Metal-on-Metal Bearing or Corrosion at the Head-Neck Junction.

Kamil T. Okroj; Tyler E. Calkins; Erdan Kayupov; Michael M. Kheir; Joshua S. Bingham; Christopher P. Beauchamp; Javad Parvizi; Craig J. Della Valle

BACKGROUND In patients with adverse local tissue reaction (ALTR) secondary to a failed metal-on-metal (MoM) bearing or corrosion at the head-neck junction in a metal-on-polyethylene bearing, ruling in or out periprosthetic joint infection (PJI) can be challenging. Alpha-defensin has emerged as an accurate test for PJI. The purpose of this multicenter, retrospective study was to evaluate the accuracy of the alpha-defensin synovial fluid test in detecting PJI in patients with ALTR. METHODS We reviewed medical records of 26 patients from 3 centers with ALTR that had an alpha-defensin test performed. Patients were assessed for PJI using the Musculoskeletal Infection Society criteria. Thirteen of these subjects had MoM total hip arthroplasty, 9 had ALTR secondary to head-neck corrosion, and 4 had MoM hip resurfacing. RESULTS Only 1 of the 26 patients met Musculoskeletal Infection Society criteria for infection. However, 9 hips were alpha-defensin positive, including 1 true positive and 8 that were falsely positive (31%). All 8 of the false positives were also Synovasure positive, although 5 of 8 had an accompanying warning stating the results may be falsely positive due to a low synovial C-reactive protein value. CONCLUSION Similar to synovial fluid white blood cell count, alpha-defensin testing is prone to false-positive results in the setting of ALTR. Therefore, we recommend an aggressive approach to ruling out PJI including routine aspiration of all hips with ALTR before revision surgery to integrate the synovial fluid blood cell count, differential, cultures and adjunctive tests like alpha-defensin to allow for accurate diagnosis preoperatively.


Arthroplasty today | 2017

Are patients being evaluated for periprosthetic joint infection prior to referral to a tertiary care center

Matthew W. Tetreault; Kenneth Estrera; Erdan Kayupov; Caroline Brander; Craig J. Della Valle

Background Patients with a painful or failed total joint arthroplasties should be evaluated for periprosthetic joint infection (PJI). The purpose of this study is to determine if patients referred to a tertiary care center had been evaluated for PJI according to the American Academy of Orthopaedic Surgeons (AAOS) clinical practice guidelines. Methods One hundred thirteen patients with painful hip (43) or knee (70) arthroplasties were referred to a single provider by orthopaedic surgeons outside our practice between 2012 and 2014. We retrospectively evaluated the workup by referring physicians, including measurement of serum erythrocyte sedimentation rate and C-reactive protein, performance of a joint aspiration if these values were abnormal, and obtainment of synovial fluid white blood cell count, differential, and cultures. Results Sixty-two of 113 patients (55%) did not have a workup that followed AAOS guidelines. Serum erythrocyte sedimentation rate and C-reactive protein were ordered for 64 of the 113 patients (57%). Of 25 patients with elevated inflammatory markers warranting aspiration, 15 (60%) had an aspiration attempted, with synovial fluid white blood cell, differential, and cultures obtained in 9 of 12 (75%) aspirations that yielded fluid. Of the 62 patients with an incomplete infection workup, 11 (18%) had a bone scan, 6 (10%) a computed tomography scan, and 3 (5%) a magnetic resonance imaging. Twelve of the 113 patients (11%) were ultimately diagnosed with PJI, with 5 undiagnosed prior to referral. Conclusions The AAOS guidelines to evaluate for PJI are frequently not being followed. Improving awareness of these guidelines may avoid unnecessary and costly evaluations and delay in the diagnosis of PJI.


Archive | 2015

Periprosthetic Infection: Management of Early Postoperative Infection

Craig J. Della Valle; Erdan Kayupov

Deep periprosthetic joint infection (PJI) in the early postoperative period, defined as within the first 6 weeks postoperatively, is among the most dreaded complications following total knee arthroplasty. Diagnosis can be challenging as normal postoperative pain, swelling, and peri-incisional inflammation can cloud normal cues to diagnosis. Based on work from our center, we recommend the use of the serum C-reactive protein (CRP) as a screening test with an optimal threshold of approximately 100 mg/L (normal <10 mg/L); a value above or near this threshold should prompt an aspiration of the joint. Aspirated fluid should be sent for a synovial fluid white blood cell (WBC) count and differential, with optimal cutoff values during the first 6 weeks postoperatively of approximately 10,000 WBC/μ[mu]L and 90 %, respectively. In cases where the clinician is still unsure if a deep infection is present, synovial fluid cultures can be obtained and monitored, with the final decision on the treatment plan based on their results.


Journal of Arthroplasty | 2016

The James A. Rand Young Investigator's Award: A Randomized Controlled Trial of Oral and Intravenous Tranexamic Acid in Total Knee Arthroplasty: The Same Efficacy at Lower Cost?

Yale A. Fillingham; Erdan Kayupov; Darren R. Plummer; Mario Moric; Tad L. Gerlinger; Craig J. Della Valle


Journal of Bone and Joint Surgery, American Volume | 2017

Oral and Intravenous Tranexamic Acid Are Equivalent at Reducing Blood Loss Following Total Hip Arthroplasty: A Randomized Controlled Trial.

Erdan Kayupov; Yale A. Fillingham; Kamil T. Okroj; Darren R. Plummer; Mario Moric; Tad L. Gerlinger; Craig J. Della Valle


Journal of Arthroplasty | 2016

Is Hypoalbuminemia Associated With Septic Failure and Acute Infection After Revision Total Joint Arthroplasty? A Study of 4517 Patients From the National Surgical Quality Improvement Program

Daniel D. Bohl; Mary R. Shen; Erdan Kayupov; Gregory L. Cvetanovich; Craig J. Della Valle


Journal of Arthroplasty | 2018

Response to the Letter to the Editor on “Continuous Adductor Canal Blocks Provide Superior Ambulation and Pain Control Compared to Epidural Analgesia for Primary Knee Arthroplasty: A Randomized, Controlled Trial”

Erdan Kayupov; Mario Moric; Craig J. Della Valle


Journal of Bone and Joint Surgery-british Volume | 2017

ARE PATIENTS BEING EVALUATED FOR PERIPROSTHETIC JOINT INFECTION PRIOR TO REFERRAL TO A TERTIARY CARE CENTRE

C.J. Della Valle; Matthew W. Tetreault; Kenneth Estrera; Erdan Kayupov; C. Brander

Collaboration


Dive into the Erdan Kayupov's collaboration.

Top Co-Authors

Avatar

Craig J. Della Valle

Rush University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Mario Moric

Rush University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Kamil T. Okroj

Rush University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Tad L. Gerlinger

Rush University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Daniel D. Bohl

Rush University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Darren R. Plummer

Rush University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Javad Parvizi

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Kenneth Estrera

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar

Mary R. Shen

Rush University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Matthew W. Tetreault

Rush University Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge